Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 5Thoracic 2Breast 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Triple Negative Breast Neoplasms 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 79Blood Specimen Collection 67palbociclib 40Trastuzumab 34Drug Therapy 30Letrozole 29Anastrozole 27Radiotherapy 26Immunohistochemistry 26Mastectomy, Segmental 22Amplified Fragment Length Polymorphism Analysis 22Fulvestrant 21Biopsy 21exemestane 20Tamoxifen 20Interviews as Topic 20Gene Expression Profiling 20Magnetic Resonance Spectroscopy 19ribociclib 18Specimen Handling 18Mastectomy 18Neoadjuvant Therapy 17Paclitaxel 16High-Energy Shock Waves 16Capecitabine 16trastuzumab deruxtecan 15Mammography 15Psychiatric Rehabilitation 14Polymerase Chain Reaction 13Observation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Urine Specimen Collection × Breast × Clear all
NCT04268693 2022-11-17

EDC-TNBC

George Washington University

Withdrawn
Breast

Triple Negative Breast Neoplasms

NCT00235235 2015-12-09

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Hoosier Cancer Research Network

Terminated
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡